Ingevity Corporation

NYSE:NGVT

Chemicals - Specialty

Basic Materials
$58.31 +1.13%

+$0.81 today

Market cap
$1.97B
Beta
1.19
P/E (TTM)
-20.0
EPS (TTM)
-$3.62
52W Low $39.74High $79.29

Volume 0.37M

Average 0.26M

NGVT Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Ingevity CorporationNYSE: NGVT

Research & Development · Q3 FY2026 · quarter ended Sep 2026

Research & development remains negative

Q3 FY2026 research & development was $0, compared with $7M a year earlier. Trailing-twelve-month research & development was $20.2M. Over 3 fiscal years it compounded at -2.1% a year.

Context

  • Research & development amounted to 2.4% of revenue in FY2025, up 0.4 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $5.05M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$28.4M+1.1% YoY
LTMSep 2026
$20.2M-32.2% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year+1.1%——
3-year CAGR-2.1%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
28.4M USD
Year-over-year change
+1.1%
4-year CAGR
+1.9%

Research & Development vs competitors

How NGVT compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -32.2% is the 6th highest of 7, against a peer median of -1.8%.
  • Research & development amounts to 1.8% of revenue for NGVT, versus a peer median of 1.1%.
NGVT Competitors
Research & Development for NGVT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FMCFMC CorporationLTM Mar 2026$262.9M USD-8.0%-5.4%7.7%
CCThe Chemours CompanyLTM Jun 2026$106M USD-3.6%-2.9%1.8%
ASHAshland Inc.LTM Jun 2026$55M USD+3.8%-0.6%3.0%
IOSPInnospec Inc.LTM Jun 2026$52.1M USD+4.0%+9.6%2.8%
MTXMinerals Technologies Inc.LTM Apr 2026$23.2M USD+0.0%+3.9%1.1%
NGVTIngevity CorporationLTM Sep 2026$20.2M USD-32.2%-2.1%1.8%
SKESkeena Resources LimitedLTM Sep 2026CA$0 CAD———
AAUCAllied Gold CorporationLTM Jun 2026$0 USD——0.0%
KWRQuaker Chemical CorporationLTM Sep 2026$0 USD——0.0%
OLNOlin CorporationLTM Jun 2026$0 USD-100.0%—0.0%
ELVRElevra Lithium LimitedFY2025A$0 AUD——0.0%
Peer median (excluding NGVT) —-1.8%-0.6%1.1%

Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.39B1.67B1.69B1.41B1.17B
Cost of Revenue878.7M1.1B1.22B951.7M706.1M
Gross Profit512.8M570.1M471.9M454.7M461.5M
Gross Margin36.9%34.2%27.9%32.3%39.5%
Research & Development26.3M30.3M31.8M28.1M28.4M
Selling, General & Admin179.3M198.8M183.7M166.7M171.2M
Operating Expenses205.6M229.1M215.5M194.8M199.6M
Depreciation & Amortization109.9M108.8M122.8M108.3M106.4M
EBITDA324.4M440.2M206M(329.5M)37.4M
EBITDA Margin23.3%26.4%12.2%-23.4%3.2%
Operating Income307.2M341M256.4M259.9M261.9M
Operating Margin22.1%20.4%15.2%18.5%22.4%
Interest Income4M5.8M6.3M6.9M4.4M
Interest Expense51.7M61.8M93.3M97.8M77.1M
Other Income / Expenses(144.4M)(71.4M)(266.5M)(795.5M)(404M)
Income Before Tax162.8M269.6M(10.1M)(535.6M)(142.1M)
Pre-Tax Margin11.7%16.2%-0.6%-38.1%-12.2%
Income Tax Expense44.7M58M(4.7M)(105.3M)8.2M
Net Income118.1M211.6M(5.4M)(430.3M)(167.1M)
Net Margin8.5%12.7%-0.3%-30.6%-14.3%
EPS (Basic)2.975.50(0.15)(11.85)(4.61)
EPS (Diluted)2.955.50(0.15)(11.85)(4.61)
Weighted Avg Shares39.8M38.47M36.5M36.32M36.2M
Weighted Avg Shares (Diluted)40.06M38.47M36.5M36.32M36.2M

Ingevity Corporation

NYSE:NGVT

Intrinsic Alpha fair value

Locked

Current Price

$58.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.